Dr. Hong Jiang is a Professor of Cardiology, Director of Science & Research, Fudan University Zhongshan Hospital; Shanghai leading talents，Director member of Shanghai health industry development & promotion association -Chronic Diseases Management specialist society，Deputy Director of Shanghai Institute of Clinical Bioinformatics, Deputy Director of Fudan University Center for Clinical Bioinformatics, Fudan University Zhongshan Hospital, Shanghai, China. Dr. Ming Liu is a general practitioner, Secretary of Shanghai health industry development & promotion association -Chronic Diseases Management specialist society, Fudan University Zhongshan Hospital, Shanghai, China.

• Genome-wide association studies of hypertension and several other cardiovascular diseases.- Cardiac transcriptome profile in heart diseases.- The Emerging Role of Epigenetics.- Mitochondria Genome Mutations and Cardiovascular Diseases.- GATA Transcription Factors and Cardiovascular Disease.- The Genetic Paradigm of WT1 Gene in Heart Development and Cardiac Repair.- Progress of genomics in hypertension-cardiac hypertrophy.- Progress of genomics in atherosclerosis-coronary heart disease and myocardial infarction.- Progress of genomics in cardiac conduction and rhythm disorders.- Progress of epigenetic changes in heart failure.- Progress of genetics in inherited cardiomyopathies-induced heart failure.- Warfarin and its pharmacogenomic study.- Gene therapy and genomic application in heart disease.

“There is no comparison to this well-edited and well-written volume. Congratulations to Drs. Jiang and Liu for a job well done.” (Luis F Escobar, Doody's Book Reviews, March, 2019)​

Dr. Hong Jiang is a Professor of Cardiology, Director of Science & Research, Fudan University Zhongshan Hospital; Shanghai leading talents，Director member of Shanghai health industry development & promotion association -Chronic Diseases Management specialist society，Deputy Director of Shanghai Institute of Clinical Bioinformatics, Deputy Director of Fudan University Center for Clinical Bioinformatics, Fudan University Zhongshan Hospital, Shanghai, China. Dr. Ming Liu is a general practitioner, Secretary of Shanghai health industry development & promotion association -Chronic Diseases Management specialist society, Fudan University Zhongshan Hospital, Shanghai, China.

• Genome-wide association studies of hypertension and several other cardiovascular diseases.- Cardiac transcriptome profile in heart diseases.- The Emerging Role of Epigenetics.- Mitochondria Genome Mutations and Cardiovascular Diseases.- GATA Transcription Factors and Cardiovascular Disease.- The Genetic Paradigm of WT1 Gene in Heart Development and Cardiac Repair.- Progress of genomics in hypertension-cardiac hypertrophy.- Progress of genomics in atherosclerosis-coronary heart disease and myocardial infarction.- Progress of genomics in cardiac conduction and rhythm disorders.- Progress of epigenetic changes in heart failure.- Progress of genetics in inherited cardiomyopathies-induced heart failure.- Warfarin and its pharmacogenomic study.- Gene therapy and genomic application in heart disease.

“There is no comparison to this well-edited and well-written volume. Congratulations to Drs. Jiang and Liu for a job well done.” (Luis F Escobar, Doody's Book Reviews, March, 2019)​

Dr. Hong Jiang is a Professor of Cardiology, Director of Science & Research, Fudan University Zhongshan Hospital; Shanghai leading talents，Director member of Shanghai health industry development & promotion association -Chronic Diseases Management specialist society，Deputy Director of Shanghai Institute of Clinical Bioinformatics, Deputy Director of Fudan University Center for Clinical Bioinformatics, Fudan University Zhongshan Hospital, Shanghai, China. Dr. Ming Liu is a general practitioner, Secretary of Shanghai health industry development & promotion association -Chronic Diseases Management specialist society, Fudan University Zhongshan Hospital, Shanghai, China.

• Genome-wide association studies of hypertension and several other cardiovascular diseases.- Cardiac transcriptome profile in heart diseases.- The Emerging Role of Epigenetics.- Mitochondria Genome Mutations and Cardiovascular Diseases.- GATA Transcription Factors and Cardiovascular Disease.- The Genetic Paradigm of WT1 Gene in Heart Development and Cardiac Repair.- Progress of genomics in hypertension-cardiac hypertrophy.- Progress of genomics in atherosclerosis-coronary heart disease and myocardial infarction.- Progress of genomics in cardiac conduction and rhythm disorders.- Progress of epigenetic changes in heart failure.- Progress of genetics in inherited cardiomyopathies-induced heart failure.- Warfarin and its pharmacogenomic study.- Gene therapy and genomic application in heart disease.

“There is no comparison to this well-edited and well-written volume. Congratulations to Drs. Jiang and Liu for a job well done.” (Luis F Escobar, Doody's Book Reviews, March, 2019)​